Home urinalysis test provider Inui had raised $50m from investors including Fosun and Tencent but is being bought by peer Healthy.io for just $9m.

Trading bourse owner SGX will take over the remaining 80% of the FX trading platform operator, its Asian Gateway Investments vehicle having invested $25m last year.

BBVA, USAA and Power Financial are set to exit wealth management technology provider Personal Capital in an $825m transaction.

The autoimmune disease and cancer drug developer plans to float in Hong Kong having recently secured $160m from investors including a Charoen Pokphand-backed fund.

OSF Ventures has exited the medical training game developer two years after providing $2m to take its overall funding to $15m.

The UC Berkeley-linked cell biology technology provider has raised about $215m in venture funding.

The cell biology technology provider, which counts Nikon and Varian Medical among its investors, has raised about $215m in venture funding.

SR One and Roche Venture Fund-backed Pandion Therapeutics will use the proceeds from the offering to advance a lead drug candidate for ulcerative colitis.

Facit exited McMaster University's cancer radiotherapy spinout in an upsized initial public offering after $158m in funding.

University of Kent's UltraSoc Technologies, which provides integrated circuit safety technologies, has agreed to an acquisition by Siemens.